Skip to main content
. Author manuscript; available in PMC: 2017 Jul 10.
Published in final edited form as: Exp Neurol. 2013 May 24;248:53–61. doi: 10.1016/j.expneurol.2013.05.011

Fig. 9.

Fig. 9

Replication of early deferasirox treatment fails to reproduce functional improvements after SCI. A) Analysis of open field locomotion using the BBB scale showed no differences in hindlimb function up to 9 weeks post-injury. B, C) Giving deferasirox during the first week-post-injury did not alter gray or white matter tissue sparing.